We are live on ! Find out more
CEROW

CERo Therapeutics Warrants
CEROW

Delisted

CEROW was delisted on the 30th of October, 2025.

Back to rankings

35 hedge funds and large institutions have $4.21M invested in CERo Therapeutics Warrants in 2022 Q1 according to their latest regulatory filings, with 8 funds opening new positions, 3 increasing their positions, 3 reducing their positions, and 3 closing their positions.

New
Increased
Maintained
Reduced
Closed

167% more first-time investments, than exits

New positions opened: 8 | Existing positions closed: 3

17% more funds holding

Funds holding: 30 → 35 (+5)

0% more repeat investments, than reductions

Existing positions increased: 3 | Existing positions reduced: 3

40% less capital invested

Capital invested by funds: $6.98M → $4.21M (-$2.78M)

Holders
35
Holders Change
+5
Holders Change %
+16.67%
% of All Funds
0.55%
Holding in Top 10
–
Holding in Top 10 Change
–
Holding in Top 10 Change %
–
% of All Funds
–
New
8
Increased
3
Reduced
3
Closed
3
Calls
$32K
Puts
–
Net Calls
+$32K
Net Calls Change
-$25K

Top Buyers

Rank Fund Capital Flow
1
PC
Periscope Capital
Ontario, Canada
+$111K
2
LA
Linden Advisors
New York
+$92.8K
3
MI
MMCAP International
Cayman Islands
+$92.8K
4
CCM
Context Capital Management
California
+$74.3K
5
Parallax Volatility Advisers
Parallax Volatility Advisers
California
+$42.8K

Top Sellers

Rank Fund Capital Flow
1
CL
CSS LLC
Illinois
-$12K
2
D.E. Shaw & Co
D.E. Shaw & Co
New York
-$11K
3
CF
Cantor Fitzgerald
New York
-$4.25K
4
RA
Ramius Advisors
New York
-$4K
5
CS
Clear Street
New York
-$2K
Name Holding Trade Value Shares
Change 		Change in
Stake
MP
1
Mangrove Partners
Connecticut
$1.64M – – –
RCM
2
Radcliffe Capital Management
Pennsylvania
$1.5M – – –
HCM
3
Highbridge Capital Management
New York
$92K – – –
MI
4
MMCAP International
Cayman Islands
$82K +$92.8K +250,000 +200%
CF
5
Cantor Fitzgerald
New York
$79K -$4.25K -11,452 -3%
Citadel Advisors
6
Citadel Advisors
Florida
$71K – – –
PAMP
7
Polar Asset Management Partners
Ontario, Canada
$65K – – –
PC
8
Periscope Capital
Ontario, Canada
$65K +$111K +299,800 New
SCM
9
Saba Capital Management
New York
$64K – – –
LA
10
Linden Advisors
New York
$55K +$92.8K +249,999 New
AA
11
AQR Arbitrage
Connecticut
$54K – – –
ACM
12
Atalaya Capital Management
New York
$50K – – –
SCM
13
Segantii Capital Management
Hong Kong
$50K – – –
CCM
14
Context Capital Management
California
$44K +$74.3K +200,000 New
QGA
15
Q Global Advisors
Texas
$37K +$26.3K +70,785 +71%
FTCM
16
Fir Tree Capital Management
New York
$27K – – –
Parallax Volatility Advisers
17
Parallax Volatility Advisers
California
$25K +$42.8K +115,296 New
NAM
18
Nexpoint Asset Management
Texas
$24K – – –
TI
19
Telemetry Investments
New York
$23K +$39.5K +106,297 +694%
CL
20
CSS LLC
Illinois
$19K -$12K -32,300 -27%
CH
21
CVI Holdings
Delaware
$19K – – –
WAM
22
Wolverine Asset Management
Illinois
$17K – – –
PMAM
23
Picton Mahoney Asset Management
Ontario, Canada
$17K +$27.9K +75,000 New
KPF
24
K2 Principal Fund
Ontario, Canada
$14K – – –
SCC
25
Spring Creek Capital
Kansas
$11K – – –
1
2

CEROW Hedge Fund Activity: Q1 2022 in Review

35 of the 6,341 institutional investors tracked by Wall St. Rank reported a position in CERo Therapeutics Warrants (CEROW) for Q1 2022, worth a combined $4.21M — down 40% from $6.98M a quarter earlier.

Buyers outnumbered sellers: 8 funds opened new CEROW positions and 3 closed out — a net gain of 5 holders — while 3 added to existing stakes and 3 trimmed.

The largest buyer was Periscope Capital, opening a new position worth an estimated $111K. The largest seller was CSS LLC, cutting an estimated $12K.

  • 35 institutional investors held CERo Therapeutics Warrants (CEROW) as of Q1 2022, up from 30 in Q4 2021.
  • Funds reported $4.21M of CERo Therapeutics Warrants stock for Q1 2022, down 40% quarter-over-quarter.
  • 8 funds opened new CERo Therapeutics Warrants positions in Q1 2022 and 3 closed out, a net change of +5 holders.
  • The largest CERo Therapeutics Warrants buyer in Q1 2022 was Periscope Capital, an estimated $111K added.
  • The largest CERo Therapeutics Warrants seller in Q1 2022 was CSS LLC, an estimated $12K sold.

Based on aggregated 13F filings for Q1 2022.